Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients
Authors:
- 1 August 2018
- journal article
- letter
- Published by Wolters Kluwer Health in Pancreas
- Vol. 47 (7) , e42-e43
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancerCancer Chemotherapy and Pharmacology, 2016
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011